REGENXBIO
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell REGENXBIO and other ETFs, options, and stocks.About RGNX
REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381.
RGNX Key Statistics
Stock Snapshot
As of today, REGENXBIO(RGNX) shares are valued at $14.65. The company's market cap stands at 736.6M, with a P/E ratio of -4.14.
During the trading session on 2025-12-25, REGENXBIO(RGNX) shares reached a daily high of $14.72 and a low of $14.26. At a current price of $14.65, the stock is +2.7% higher than the low and still -0.5% under the high.
Trading volume for REGENXBIO(RGNX) stock has reached 191.1K, versus its average volume of 681.87K.
The stock's 52-week range extends from a low of $5.04 to a high of $15.41.
The stock's 52-week range extends from a low of $5.04 to a high of $15.41.
RGNX News
REGENXBIO Inc. ( ) shares have continued their recent momentum with a 27% gain in the last month alone. The annual gain comes to 103% following the latest surge...
